Medical Affairs Content Strategy: Deployment & Innovation

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Activating Medical’s Customers: Boosting Performance With Content Strategy and Innovation”

STUDY OVERVIEW

With scientific exchange accelerating, Medical Affairs teams are rethinking content strategies to deliver greater impact with efficiency and scale. As digital reliance grows, leaders must balance internal vs. external use, expand reusable formats, and embrace AI-driven solutions—yet many still struggle with fragmented processes, unclear ownership, and underperforming systems.

This study explores how Medical Affairs is innovating content development and deployment, providing benchmarks on FTE allocation, reusable vs. single-use formats, and adoption of automation. The research also highlights top-performing content types for training, enablement, and scientific engagement. The findings equip executives to streamline content operations, elevate performance, and maximize value with smarter, scalable strategies.

KEY TOPICS

Content Format and Utilization
AI-Driven Content Creation and Automation
FTE Allocation for Content
Strengths and Gaps in Content Systems

KEY METRICS

Content creation – internal vs. external usage
Top content for training and enablement
Top content for scientific exchange and engagement
Average medical FTE allocation for content creation
Reusable vs. single-use content
Content strengths and weaknesses across organizations

SAMPLE KEY FINDINGS

Content Deployment: 70% of Medical content is developed for external use, with strong field interactions often requiring customized materials.
Innovation: AI and automation are increasingly used to personalize content and improve engagement outcomes.

METHODOLOGY

Best Practices, LLC captured insights from 31 Medical Affairs leaders representing 30 biopharma companies, supplemented with deep-dive interviews to uncover how Medical teams are advancing content creation and deployment strategies. Findings are further segmented by company size, delivering actionable benchmarks for meaningful peer comparison.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Diagnostic; Health Care; Service; Medical Device; Clinical Research; Laboratories

Companies Profiled:
AbbVie; Alnylam Pharmaceuticals; AstraZeneca; Axsome Therapeutics; Biogen; bioM�rieux; BIOVIIIx; Boehringer Ingelheim; Eisai; EMD Sereno; EVERSANA; Exact Sciences; ImmunityBio; Ipsen; Jazz Pharmaceuticals; Johnson & Johnson; Lantheus; Merck & Co.; Merck KGaA; Organon; Orion Pharmaceuticals; Otsuka; Premier Research; Relay Therapeutics; Sanofi; Sobi; Stallergenes Greer; Taiho Oncology; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Activating Medical’s Customers: Boosting Performance With Content Strategy and Innovation

ID: 5892

Features:

Pages/Slides: 25

Published: 2025

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FE146FA4B31A77BA00258D0E00407809
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-activating-medical-customers-content-strategy-innovation?opendocument
18
19opendocument
2018.97.9.175
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB